Tirzepatide Treatment and Associated Changes in β-Cell Function and Insulin Sensitivity in People With Obesity or Overweight With Prediabetes or Normoglycemia: A Post Hoc Analysis From the SURMOUNT-1 Trial.

Tirzepatide 治療及其對肥胖或過重且有前期糖尿病或正常血糖者 β-細胞功能與胰島素敏感度變化之相關性：SURMOUNT-1 試驗的事後分析